The data on the immunohistochemical analysis of conditional Notch ligand knockout mice is presented. Targeted deletion of Jag1, Dll1, Dll4, or Dll1 plus Dll4 in Lgr5 þ ve cells was induced by a Cremediated gene recombination, and differentiation or proliferation of the intestinal epithelial cells was examined by immunohistochemistry. These data are the extension of the data presented and discussed in the paper entitled "Indispensable role of noncanonical Notch signaling in the proliferation of Apc-deficient intestinal tumors" (Nakata et al., Submitted for publication) [1] .
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The data is valuable for future research works focused on the functional relevance of Notch signaling in intestinal epithelial cell differentiation and proliferation.
Data
The immunohistochemistry data show the proliferation and differentiation of mouse intestinal epithelial cells under the targeted deletion of Jag1, Dll1, Dll4, or Dll1 plus Dll4 genes in LGR5-EGFP-ires-CreERT; ROSA26-tdTomato mice served as control (Control). Analysis of Dll1 (green, upper series) and Dll4 (green, lower series) expression by immunohistochemistry is shown. Red signals indicate tdTomato þ ve cells. Scale bar, 100 μm.
Experimental design, materials, and methods

Mice
All the animal experiments were approved by the Animal Welfare Committee of Tokyo Medical and Dental University (Approval no. 016326A). All animal procedures were carried out in compliance with the institutional standards for use of laboratory animals. Lgr5-EGFP-ires-CreERT2 mice (Stock No. 008875) and ROSA26-tdTomato mice (Stock No. 007909) were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA). Jag1-floxed (Jag1 LGR5-EGFP-ires-CreERT2; ROSA26-tdTomato mice served as the control (Control). Cre-mediated gene recombination was induced by intraperitoneal injection of tamoxifen (TX, 2 mg/body) for 5 consecutive days, as previously described [1] [5].
Antibodies
The primary antibodies used are as follows: anti-Dll1 (1:500, AF5026, R&D systems, Minneapolis, USA), anti-Dll4 (1:500, AF1389, R&D systems, Minneapolis, USA), anti-RFP (1:500, PM005, MBL, Nagoya, Japan), anti-tdTomato kindly provided by T. Sudo, Toray, Kanagawa, Japan) [6] , anti-Ki67 (1:50, TEC-3, DAKO, Glostrup, Denmark), anti-MUC2 (1:100, SantaCruz Biotechnology, Texas, USA), anti-CgA (SP-1, Diasorin, Saluggia, Italy), anti-DCAMKL1 (1:100, AP7219B, Abgent, San Diego, USA), and anti-Lysozyme (1:1500, EC3.2.1.17, DAKO, Glostrup, Denmark).
Immunohistochemistry of mouse intestinal tissue samples
Immunohistochemistry of mouse intestinal tissues was performed as previously described [5, 7] .
Sections (8 μm) were prepared for the analysis. Antigen retrieval in citrate buffer was required for staining Dll1, Dll4, CgA and Hes1. Tyramide signal amplification was used for the immunofluorescent detection of Dll1, Dll4, CgA and Hes1. Stainings were visualized by the standard Avidin-biotin complex (ABC) method, or by secondary antibodies and tyramide substrates conjugated with Alexa-594 or Alexa-488 (Molecular Probes, California, USA). Tissues were counterstained by 4',6-diamidino-2-phenylindole (DAPI) or by hematoxylin. Data were collected using an epifluorecent microscope (BZ-X700, KEYENCE, Tokyo, Japan). Fig. 4 . Data shows mean7 SEM of triplicate experiments (n ¼3). * indicates P o 0.05, ** indicates P o0.01, *** indicates P o 0.001 as determined by Student' s t-test. n.s. indicates not significant.
Funding
